How is the Cardiac Marker Testing Market Poised for Growth: Trends and Opportunities Through 2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What fueled the previous growth in the cardiac marker testing market?
The cardiac marker testing market has experienced rapid expansion, anticipated to grow from $6.52 billion in 2024 to $7.19 billion in 2025, with a CAGR of 10.3%. Key factors driving this growth include an aging population, educational campaigns, increased awareness, enhanced healthcare infrastructure, and a growing patient base.
What will be the cardiac marker testing market size in the future?
The cardiac marker testing market is projected to witness rapid growth, reaching $10.56 billion by 2029, with a CAGR of 10.1%. Growth is driven by increasing cases of cardiovascular diseases, strategic collaborations and partnerships, rising research and development initiatives, favorable reimbursement policies, and higher demand for point-of-care testing. Major trends include advanced diagnostic technologies, automated analyzers, enhanced cardiac marker testing assays, the adoption of digital health technologies, and the emergence of integrative testing solutions.
Get your cardiac marker testing market report here!
https://www.thebusinessresearchcompany.com/report/cardiac-marker-testing-global-market-report
What main drivers are fueling expansion in the cardiac marker testing market?
The rising incidence of cardiovascular diseases is fueling the cardiac marker testing market. CVDs, including heart disease and stroke, are linked to unhealthy diets, physical inactivity, tobacco use, alcohol consumption, and air pollution. Cardiac marker testing helps diagnose, monitor, and assess heart conditions by detecting biomarkers released during heart damage. According to the American Heart Association, the US age-adjusted death rate from cardiovascular disease increased by 4.0% to 233.3 per 100,000 in 2024 from 224.4 per 100,000 in 2023, with sudden cardiac arrest causing 20,114 deaths in 2021. This rise in CVD cases is propelling the cardiac marker testing market.
What key areas define the segmentation of the global cardiac marker testing market?
The cardiac marker testingmarket covered in this report is segmented –
1) By Product: Reagents And Kits, Instruments
2) By Biomarker Type: Troponin I And T, Creatine Kinase-MB (CK-MB), Natriuretic Peptide, Myoglobin, High-Sensitivity C-Reactive Protein, Other Cardiac Biomarkers
3) By Application: Laboratory Testing Facilities, Point-Of-Care Testing Facilities, Academic Institutions
Subsegments:
1) By Reagents and Kits: Troponin Test Kits, B-type Natriuretic Peptide (BNP) Test Kits, Creatine Kinase-MB (CK-MB) Test Kits, Myoglobin Test Kits, Other Cardiac Biomarker Reagents
2) By Instruments: Point-of-Care Testing Devices, Automated Analyzers, Immunoassay Systems, Portable Diagnostic Devices
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19358&type=smp
Who are the dominant players expanding their reach in the cardiac marker testing market?
Major companies operating in the cardiac marker testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Quest Diagnostics Inc., Tosoh Corporation, bioMérieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., Guangzhou Wondfo Biotech Co. Ltd., Randox laboratories Ltd., Getein Biotech Inc., Fujirebio Inc., Mayo Clinic Laboratories, Kainos Medicine Inc., Alere Inc., Nano-Ditech Corporation, 1Drop Diagnostics
How are evolving market trends shaping cardiac marker testing Strategies?
In the cardiac marker testing market, prominent companies are concentrating on creating highly advanced products like cardiac assays. These products are beneficial in procuring precise details about the health and functioning of the heart. Diagnostic tests such as cardiac assays are useful in evaluating heart functionality, identifying cardiovascular diseases, and ascertaining the risk of heart-related problems by measuring biomarkers in blood or other samples. Case in point, Mindray, a medical device firm based in China, in October 2023, introduced the troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers. Notably, the hs-cTnI assay stands out for its incredible sensitivity, accuracy, and dependability. It well exceeds the bare requirements by attaining a 93% detection success rate between the limit of detection (LoD) and the 99th percentile upper reference limit (URL). It remains remarkably effective in diagnosing myocardial injury by having a coefficient of variation (CV) under 5% at the 99th URL. Mindray’s NT-proBNP assay, a critical cardiac marker for heart failure, demonstrates high precision with a CV of ≤5%. Moreover, it significantly reduces the interference from 55 prevalent heart disease drugs, which enables accurate prediction and control of heart failure.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19358
Which regions are emerging as leaders in the cardiac marker testing market?
North America was the largest region in the cardiac marker testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac marker testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Cardiac Rhythm Management (CRM) Devices And Equipment Global Market Report 2024
Cardiac Assist Devices And Equipment Global Market Report 2024
Cardiac Arrhythmia Monitoring Devices Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
